M&A TRANSACTION · 2020
nThrive RCM Technology Division acquired by Clearlake Capital Group, LP
$1.00B· 10.0x EBITDA
Target
nThrive RCM Technology Division
Acquirer
Clearlake Capital Group, LP
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$100.0M
Deal Value
$1.00B
EV/EBITDA
10.0x
Context
This $1.00B acquisition of nThrive RCM Technology Division by Clearlake Capital Group, LP sits in the healthcare it sub-vertical. The 10.0x EBITDA multiple paid in 2020 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. Clearlake Capital Group, LP is acquiring as a private equity buyer; see how PE acquirers typically price healthcare it businesses on our Healthcare It PE buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own healthcare it
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the nThrive RCM Technology Division acquisition.